Shopping Cart 0
Cart Subtotal
AED 0

Bayer Healthcare Pharmaceuticals-Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Bayer Healthcare Pharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketline's Bayer Healthcare Pharmaceuticals Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Bayer Healthcare Pharmaceuticals since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Bayer Healthcare Pharmaceuticals's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Bayer Healthcare Pharmaceuticals. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Bayer Healthcare Pharmaceuticals's M&A, strategic partnerships and alliances, capital raising and private equity transactions.

- Detailed reports of various financial transactions undertaken by Bayer Healthcare Pharmaceuticals and its subsidiaries since 2007.

- Information about key financial and legal advisors for Bayer Healthcare Pharmaceuticals's financial deals transactions.

- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

- Form an independent opinion about Bayer Healthcare Pharmaceuticals's growth strategies through the organic and inorganic activities undertaken since 2007.

- Track your competitors' business structure and growth strategies.

READ MORE

Table Of Content

Scope

Table of Contents

COMPANY OVERVIEW AND KEY FACTS 2

TABLE OF CONTENTS 4

LIST OF TABLES 5

LIST OF FIGURES 5

TARGETS AND PARTNERS 6

MERGERS & ACQUISITIONS 7

Mergers and Acquisitions - Deal reports 7

PARTNERSHIP 10

Partnership - Overview 10

Partnership - Deal reports 11

APPENDIX 258

Contact Us 258

About MarketLine Financial Deals Database 258

Deal Definition and Methodology 260

About MarketLine 267


List Of Figure

List of Figures

Figure 1: Bayer Healthcare Pharmaceuticals partnership volume and value trend (2014-YTD2018)

Figure 2: Bayer Healthcare Pharmaceuticals partnership trend by key deal type (2014-YTD2018)


List Of Table

List of Tables

Table 1: Bayer Healthcare Pharmaceuticals partnership volume and value trend (2014-YTD2018)

Table 2: Bayer Healthcare Pharmaceuticals partnership trend by key deal type (2014-YTD2018)

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Bayer Healthcare Pharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketline's Bayer Healthcare Pharmaceuticals Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Bayer Healthcare Pharmaceuticals since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Bayer Healthcare Pharmaceuticals's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Bayer Healthcare Pharmaceuticals. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Bayer Healthcare Pharmaceuticals's M&A, strategic partnerships and alliances, capital raising and private equity transactions.

- Detailed reports of various financial transactions undertaken by Bayer Healthcare Pharmaceuticals and its subsidiaries since 2007.

- Information about key financial and legal advisors for Bayer Healthcare Pharmaceuticals's financial deals transactions.

- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

- Form an independent opinion about Bayer Healthcare Pharmaceuticals's growth strategies through the organic and inorganic activities undertaken since 2007.

- Track your competitors' business structure and growth strategies.

READ MORE

Scope

Table of Contents

COMPANY OVERVIEW AND KEY FACTS 2

TABLE OF CONTENTS 4

LIST OF TABLES 5

LIST OF FIGURES 5

TARGETS AND PARTNERS 6

MERGERS & ACQUISITIONS 7

Mergers and Acquisitions - Deal reports 7

PARTNERSHIP 10

Partnership - Overview 10

Partnership - Deal reports 11

APPENDIX 258

Contact Us 258

About MarketLine Financial Deals Database 258

Deal Definition and Methodology 260

About MarketLine 267


List Of Figure

List of Figures

Figure 1: Bayer Healthcare Pharmaceuticals partnership volume and value trend (2014-YTD2018)

Figure 2: Bayer Healthcare Pharmaceuticals partnership trend by key deal type (2014-YTD2018)


List Of Table

List of Tables

Table 1: Bayer Healthcare Pharmaceuticals partnership volume and value trend (2014-YTD2018)

Table 2: Bayer Healthcare Pharmaceuticals partnership trend by key deal type (2014-YTD2018)

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com